02/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/2024

Feb 14, 2024, 18:56 | Blog
Melanie Sisk: We are looking for volunteers who want to make a tangible impact in the lives of patients whose cancer has the PIK3CA mutation
Melanie Sisk, Metastatic Breast Cancer Patient Advocate, shared on X/Twitter: "Hello PIK3CA members. We are looking…
Feb 14, 2024, 18:37 | Blog
Naveen Pemmaraju: Important brainstorming sessions today with Team Pemm for new ideas in MPNSM & BPDCN!
Naveen Pemmaraju shared on X: “Important brainstorming sessions today with Team Pemm for new ideas…
Feb 14, 2024, 18:13 | Drugs
Liposomal Irinotecan now FDA Oncology approved for 1L metastatic Pancreatic Cancer based off NAPOLI3 - Oncology Brothers
Oncology Brothers made the following post on X: "Liposomal Irinotecan now FDA Oncology approved for…
Feb 14, 2024, 18:02 | Blog
Mark Lewis: Dr. Andrew Ko’s observation at ASCO23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX!
Mark Lewis shared on X: “Seems relevant to resurface Dr. Andrew Ko’s observation at ASCO23…
Feb 14, 2024, 17:54 | Blog
This commentary by Donald Harvey et al. is a call to action for a concerted commitment to transform clinical trials - ACS Journal Cancer
ACS Journal Cancer posted on X: “This commentary by Donald Harvey et al. is a…
Feb 14, 2024, 17:42 | Blog
Lynn Schuchter: Please work with your colleagues to mitigate these drug shortages
Lynn Schuchter recently shared on X: “Drug shortages are impacting thousands of individuals w/ cancer, including…
Feb 14, 2024, 14:59 | Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
Feb 14, 2024, 13:50 | Drugs
Robert Z. Orlowski: Myeloma Paper of the Day
Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, posted on X/Twitter:…
Feb 14, 2024, 13:47 | Blog
Laura Esfeller: Humbled to share I’m the new podcast host for the Judy Nicholson Kidney Cancer Foundation!
Laura Esfeller, Director of Marketing Services at San Manuel Band of Mission Indians, shared on…
Feb 14, 2024, 13:40 | Insight
Karen Bedirian: Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: "Happy to share…
All: 756 Posts: 401 - 410
Special Coverage